Surface and molecular expression of complement-receptor type 2 of neoplastic CD5+ B cells in chronic lymphocytic leukemia.
Tooze
J A
JA
Department of Cellular and Molecular Sciences, St. George's Hospital Medical School, London, United Kingdom.
Bevan
D H
DH
Lever
A M
AM
D015703:Antigens, CD / Q000032:analysis*; D016175:B-Lymphocyte Subsets / Q000276:immunology*; D015152:Blotting, Northern; D018956:CD5 Antigens; D005312:Fetal Blood / Q000276:immunology; D004854:Herpesvirus 4, Human; D006801:Humans; D016130:Immunophenotyping; D007231:Infant, Newborn; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000276:immunology*; D014066:Palatine Tonsil / Q000276:immunology; D012333:RNA, Messenger / Q000032:analysis / Q000235:genetics; D012334:RNA, Neoplasm / Q000235:genetics / Q000302:isolation & purification; D011951:Receptors, Complement / Q000032:analysis / Q000235:genetics*; D017464:Receptors, Complement 3d; D011991:Receptors, Virus / Q000032:analysis / Q000235:genetics; D012016:Reference Values
D015703:Antigens, CD; D018956:CD5 Antigens; D012333:RNA, Messenger; D012334:RNA, Neoplasm; D011951:Receptors, Complement; D017464:Receptors, Complement 3d; D011991:Receptors, Virus